This week, we will be discussing a randomized controlled trial of eculizumab in STEC-HUS. Will eculizumab manage to surpass its well-established reputation as expensivumab and demonstrate some positive results?
ECULIZUMAB in STEC - HUS - a Visual Abstract
Is eculizumab effective in pediatric patients with Shiga toxin-related E. Coli hemolytic uremic syndrome?
Check out the visual abstract by Melvin Chan for the answer.